Physician profile
Dana C Johnson
NPI 1235556671
$103,555.00
in general payments reported to CMS, 2019-2025
24 companies · $42K in 2025
The $42K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $10K · 2021: $32K · 2022: $4,057 · 2023: $3,568 · 2024: $11K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $18K · Consulting Fee: $17K · Food and Beverage: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,900 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $18,378.21 |
| Consulting Fee | $16,538.00 |
| Food and Beverage | $12,885.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,900.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $30,838.69 | 2019-2025 | Ensite, Ensite Precision |
| Medtronic, INC. | $29,833.90 | 2021-2025 | Selectsecure, Cobalt Dr Mri Surescan, Sphere-9 |
| Biotronik INC. | $16,992.49 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Biosense Webster, INC. | $10,905.21 | 2020-2025 | Carto 3, Qdot Micro Catheter |
| Boston Scientific Corporation | $10,690.91 | 2019-2025 | General - Therapies, Watchman Access System, Farapulse |
| Altathera Pharmaceuticals LLC | $2,263.17 | 2025 | Sotalol Hydrochloride |
| Medical Device Business Services, INC. | $835.57 | 2020 | |
| Becton, Dickinson and Company | $277.25 | 2024-2025 | Hemosphere |
| Atricure, INC. | $178.42 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Cardiva Medical, INC. | $131.22 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Edwards Lifesciences Corporation | $107.20 | 2024 | Hemosphere |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $92.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $84.79 | 2022-2023 | Xarelto |
| Abiomed | $70.48 | 2025 | |
| Terumo Medical Corporation | $52.40 | 2022-2023 | Optitorque |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $39.62 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.49 | 2019 | |
| Zoll Circulation INC | $28.09 | 2019 | |
| Getinge USA Sales, LLC | $19.41 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $17.67 | 2019 | |
| Cordis US Corp. | $16.69 | 2024 | Mynx Venous Vcd |
| Ekos Corporation | $14.30 | 2019 | |
| Chiesi USA, INC. | $13.90 | 2024 | Cleviprex, Kengreal |
| Cardinal Health 200 LLC | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.